Evommune, Inc. (EVMN) › Operating IncomeEvommune, Inc. (EVMN) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2024: -$70.01M2025: -$81.07M-$81.07M2024Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$81.07M-15.8%2024-$70.01M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share